The Defense Health Agency awarded a $1,535,920.00 Project Grant to the Translational Genomics Research Institute (TGen) under the Military Medical Research and Development program (CFDA 12.420). The grant supports TGen's research on genomic structural mutations associated with telomere dysfunction in glioblastoma cells and patients. The 4-year project will utilize advanced genomic analysis and sequencing techniques to gain insights into the molecular mechanisms driving glioblastoma, a highly aggressive form of brain cancer. The findings from this research could lead to improved diagnostics and treatments for glioblastoma, with potential applications for the U.S. military and broader patient populations.
Generated 5/7/24, 6:01 AM